美国18-49岁乙肝高危成人保护性表面抗体流行趋势(2003-2014)
基于2003-2014年美国国家健康与营养调查数据,纳入18-49岁、接受HBV检测且报告至少一项感染风险的成人,评估抗-HBs≥10 mIU/mL的流行率与趋势。总体阳性率为23.4%,由2003-2006年的16.3%升至2007-2010年的27.3%,2011-2014年为28.1%且较前一阶段无变化。年轻和较高教育程度与抗-HBs阳性相关。
要点
- 高危成人抗-HBs≥10 mIU/mL总体阳性率仅23.4%,多数未获保护。
- 阳性率从2003-2006年16.3%升至2007-2010年27.3%,此后至2011-2014年无变化。
- 年轻年龄与较高教育程度与抗-HBs阳性相关,需针对性干预。
核心结论
- 至2014年,18-49岁有感染风险的成人中不足三分之一具有保护性抗-HBs≥10 mIU/mL。
- 这些成人占未受保护成人的多数,需靶向干预策略以实现乙肝消除目标。
研究设计与样本
- 数据来自2003-2014年美国国家健康与营养调查(NHANES)。
- 样本为18-49岁接受HBV检测且报告至少一项感染风险的成人,风险包括性传播疾病史、男性与男性性行为、HIV感染和注射吸毒。
- 按三个4年时间段(2003-2006、2007-2010、2011-2014)计算抗-HBs≥10 mIU/mL的流行率,并用Cochran-Mantel-Haenszel检验评估趋势。
- 采用多因素logistic回归分析与抗-HBs阳性相关的因素。
主要发现
- 抗-HBs阳性血清学总体流行率为23.4%。
- 流行率从2003-2006年的16.3%升至2007-2010年的27.3%,但2007-2010年(27.3%)至2011-2014年(28.1%)无变化。
- 预测抗-HBs阳性的因素包括年轻年龄和较高教育程度。
关键数值与推荐
- 保护性抗体判定标准为抗-HBs≥10 mIU/mL,提示疫苗接种获得的免疫。
- 2003-2006年阳性率16.3%,2007-2010年27.3%,2011-2014年28.1%。
临床怎么用
- 对18-49岁有性传播疾病史、男性与男性性行为、HIV感染或注射吸毒等风险者应评估乙肝疫苗接种与抗体状态。
- 鉴于保护率不足三分之一且近年无改善,需对高危成人开展针对性疫苗接种与筛查干预。
局限性
- 研究基于NHANES调查数据,风险因素依赖自我报告,可能存在遗漏或错分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hepatitis B virus (HBV) infection can be prevented through vaccination. However, previous data show that only about 24%-45% of US adults at high risk of HBV infection are protected. Our aims were to assess prevalence and trends in protective levels of hepatitis B surface antibody (anti-HBs) from 2003 to 2014 and explore factors associated with protection among adults at high risk. METHODS: Data were taken from the 2003-2014 National Health and Nutrition Examination surveys. Our sample included adults aged 18-49 years who were tested for HBV and reported at least 1 of the following infection risks: history of sexually transmitted disease, sex with men (for men), infection with human immunodeficiency virus, and injection drug use. We calculated the prevalence of anti-HBs (≥10 mIU/mL), indicative of immunity from vaccination, among respondents for three 4-year time intervals (2003-2006, 2007-2010, and 2011-2014) and applied the Cochran-Mantel-Haenszel test to assess trends. Using multivariable logistic regression, we examined factors associated with positive anti-HBs serology. RESULTS: The prevalence of positive anti-HBs serology was 23.4%. Prevalence increased from 2003-2006 (16.3%) to 2007-2010 (27.3%), but no change occurred from 2007-2010 (27.3%) to 2011-2014 (28.1%). Among factors predicting positive anti-HBs serology were young age and higher education. CONCLUSIONS: By 2014, less than one-third of adults aged 18-49 years at risk of infection exhibited protective antibodies ≥10 mIU/mL. Because these adults account for a majority of unprotected adults, targeted intervention strategies are essential to achieve the hepatitis B elimination goal.
引用
- King H, Xing J, Dean HD, et al. Trends in Prevalence of Protective Levels of Hepatitis B Surface Antibody Among Adults Aged 18-49 Years With Risk Factors for Hepatitis B Virus Infection-United States, 2003-2014. Clin Infect Dis. 2020. PMID: 31228240. doi:10.1093/cid/ciz537
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。